MiR-182 is a newly discovered RNA molecule that has potentially momentous influence on the way we treat glioblastoma mulitforme, the deadliest known variant of brain cancer. According to a study conducted at the Feinberg School of Medicine in Northwestern University, this small molecule has the ability to suppress cancer at the source by repressing certain genes … Read More

We all know the saying that dogs are our best friends. However, a new study suggests that this bond may transcend mere friendship: studying dogs might help us cure glioblastoma, the most deadly variant of brain cancer. This study, conducted at the Swedish University of Agricultural Science and Uppsala University, suggests that analyzing the underlying … Read More

The concept may sound crazy at first. Killing brain cancer cells with skin cells. How could that possibly work? Well, pharmacy researchers at University of North Carolina, Chapel Hill have successfully been able to turn skin cells into, essentially, brain cancer cell predators–cells that search and destroy brain tumors. The concept of reprogramming skin cells is not … Read More

Scientists at the Feinberg School of Medicine associated with Northwestern University have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma multiforme (GBM), one of the deadliest variants of brain cancer. Currently, there is no cure for the disease. Embed from Getty Images Research has shown success in the … Read More

Nobody wants to hear a cancer diagnosis–especially not a prognosis of glioblastoma, a deadly variant of brain cancer where patients typically survive only 15 months following diagnosis. But what makes glioblastoma so deadly? A separate study conducted three years ago discovered that this aggressive brain tumor grows by turning normal brain cells (i.e. neurons) into stem … Read More

Back to top